We serve Chemical Name:6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole CAS:1158680-88-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
CAS.NO:1158680-88-6
Synonyms:6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
Molecular Formula:C12H13BrN2O
Molecular Weight:281.14800
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:27.05000
Exact Mass:280.02100
LogP:3.49790
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole Use and application,6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole technical grade,usp/ep/jp grade.
Related News: Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications. 6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole manufacturer Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies. 6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole supplier Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). 6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole vendor Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). 6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole factory Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies.
